Form D · Other Health Care
Innovein, Inc.
Santa Rosa, CA · CIK 0001745398
Offering snapshot reported Feb 6, 2023 · SEC filing
- Reported sold
- $2.55M Offering amount: $11.9M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jan 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2023 | Initial | $2,545,164 | No comparison | 7 | SEC filing |
| Oct 10, 2018 | Amendment | $10,748,933 | $4,213,398vs Jul 3, 2018 | 66 | SEC filing |
| Jul 3, 2018 | Initial | $6,535,535 | No comparison | 55 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-472724
Source: Form D, filed Feb 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Albert K. Chin | Director |
| David Hovda | Director, Executive |
| Thomas A. Kramer | Executive |
| Austin Walker | Director |
| Robert Whirley | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1745 Copperhill Parkway Suite 7
Santa Rosa, CA, 95403
Santa Rosa, CA, 95403